These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27226574)
21. Semen-derived amyloidogenic peptides-Key players of HIV infection. Lee YH; Ramamoorthy A Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036 [TBL] [Abstract][Full Text] [Related]
22. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide. Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963 [TBL] [Abstract][Full Text] [Related]
23. Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture. Tang Q; Roan NR; Yamamura Y J Virol; 2013 Dec; 87(23):12583-91. PubMed ID: 24027327 [TBL] [Abstract][Full Text] [Related]
25. ADS-J1 disaggregates semen-derived amyloid fibrils. Li J; Yang Z; Liu H; Qiu M; Zhang T; Li W; Li Z; Qi T; Qiu Y; Li L; Zhou X; Liu S; Tan S Biochem J; 2019 Mar; 476(6):1021-1035. PubMed ID: 30877194 [TBL] [Abstract][Full Text] [Related]
26. K114 (trans, trans)-bromo-2,5-bis(4-hydroxystyryl)benzene is an efficient detector of cationic amyloid fibrils. Selmani V; Robbins KJ; Ivancic VA; Lazo ND Protein Sci; 2015 Mar; 24(3):420-5. PubMed ID: 25524064 [TBL] [Abstract][Full Text] [Related]
27. A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection. Chen J; Ren R; Yu F; Wang C; Zhang X; Li W; Tan S; Jiang S; Liu S; Li L Biophys J; 2017 Oct; 113(7):1425-1439. PubMed ID: 28978437 [TBL] [Abstract][Full Text] [Related]
28. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection]. Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062 [TBL] [Abstract][Full Text] [Related]
29. Dual concentration-dependent effect of ascorbic acid on PAP(248-286) amyloid formation and SEVI-mediated HIV infection. Mohapatra S; Viswanathan GKK; Wettstein L; Arad E; Paul A; Kumar V; Jelinek R; Münch J; Segal D RSC Chem Biol; 2021 Oct; 2(5):1534-1545. PubMed ID: 34704058 [TBL] [Abstract][Full Text] [Related]
30. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection. Capule CC; Brown C; Olsen JS; Dewhurst S; Yang J J Am Chem Soc; 2012 Jan; 134(2):905-8. PubMed ID: 22239120 [TBL] [Abstract][Full Text] [Related]
31. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues. Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984 [TBL] [Abstract][Full Text] [Related]
32. 3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor. Zhang X; Chen J; Yu F; Wang C; Ren R; Wang Q; Tan S; Jiang S; Liu S; Li L Front Microbiol; 2018; 9():1330. PubMed ID: 29971062 [TBL] [Abstract][Full Text] [Related]
33. Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity. Sheik DA; Chamberlain JM; Brooks L; Clark M; Kim YH; Leriche G; Kubiak CP; Dewhurst S; Yang J Langmuir; 2017 Mar; 33(10):2596-2602. PubMed ID: 28207276 [TBL] [Abstract][Full Text] [Related]
35. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623 [TBL] [Abstract][Full Text] [Related]
36. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Easterhoff D; Ontiveros F; Brooks LR; Kim Y; Ross B; Silva JN; Olsen JS; Feng C; Hardy DJ; Dunman PM; Dewhurst S Antimicrob Agents Chemother; 2013 Jun; 57(6):2443-50. PubMed ID: 23507280 [TBL] [Abstract][Full Text] [Related]
37. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198 [TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection. Zhou RH; Guo L; Liu JB; Liu H; Hou W; Ma TC; Wang X; Wu JG; Ye L; Ho WZ; Li JL J Acquir Immune Defic Syndr; 2017 Jun; 75(2):232-240. PubMed ID: 28328549 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles. Sheik DA; Brooks L; Frantzen K; Dewhurst S; Yang J ACS Nano; 2015 Feb; 9(2):1829-1836. PubMed ID: 25619867 [TBL] [Abstract][Full Text] [Related]
40. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV]. Duan JM; Qiu JY; Tan SY; Liu SW; Li L Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]